Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001558370-20-005771
Filing Date
2020-05-07
Accepted
2020-05-07 17:02:07
Documents
4
Effectiveness Date
2020-05-07

Document Format Files

Seq Description Document Type Size
1 S-8 acrs-20200507xs8.htm S-8 125802
2 EX-5.1 acrs-20200507xex5d1.htm EX-5.1 11025
3 EX-23.1 acrs-20200507xex23d1.htm EX-23.1 2403
4 GRAPHIC acrs-20200507xex5d1002.jpg GRAPHIC 4113
  Complete submission text file 0001558370-20-005771.txt   146051
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-238079 | Film No.: 20857443
SIC: 2834 Pharmaceutical Preparations